Product
BR3005-2
2 clinical trials
1 indication
Indication
Type 2 Diabetes MellitusClinical trial
An Open Label, Randomized, Fasting, Single Dose, 2-sequence, 2-period, Crossover Study to Compare the Pharmacokinetics and the Safety Between a Fixed-dose Combination Administration of "BR3005" and Co-administration of "BR3005-1" and "BR3005-2" in Healthy Adult VolunteersStatus: Recruiting, Estimated PCD: 2024-03-01
Clinical trial
An Open Label, Randomized, Fed, Single Dose, 2-sequence, 2-period, Crossover Study to Compare the Pharmacokinetics and the Safety Between a Fixed-dose Combination Administration of "BR3005" and Co-administration of "BR3005-1" and "BR3005-2" in Healthy Adult VolunteersStatus: Recruiting, Estimated PCD: 2024-03-01